Yuan Qi

23PUBLICATIONS
158CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 17, 2026
Targeting p300 Reverses Acidic Microenvironment-Induced PARP Inhibitor Resistance.

|Jun 16, 2026
Nuclear export of R-loop by the DDX1 and XPO1 complex promotes senescence-associated secretory phenotype and inflammaging.

|Apr 10, 2026
Resistance to neoadjuvant talazoparib in triple-negative breast cancer by BRN2-induced ATR/STAT3 pathways or SHLD2 subclone expansion.

Noor M Abdulkareem, Yan Jiang, Yuan Qi

|Apr 03, 2026
Regulation of mitochondrial ROS by C15ORF48 in a basal cell subpopulation contributes to chemotherapy resistance in TNBC.

Yan Jiang, Noor M Abdulkareem, Amanda L Rinkenbaugh

|Aug 13, 2025
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy.

Amanda L Rinkenbaugh, Yuan Qi, Shirong Cai

|Jul 14, 2025
Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer.

Hao Nie, Liping Liao, Rafal J Zielinski

Pageof 4

Frequent Collaborators

9 joint publications

Guillermina Lozano

5 joint publications

Xiaoping Su

5 joint publications

Rugang Zhang

5 joint publications

Helen Piwnica-Worms